MCRB - Seres Therapeutics Inc. (MCRB) Q1 2024 Earnings Call Transcript

2024-05-11 17:34:06 ET

Seres Therapeutics, Inc. (MCRB)

Q1 2024 Results Conference Call

May 08, 2024 08:30 AM ET

Company Participants

Carlo Tanzi - IR

Eric Shaff - CEO

Terri Young - Chief Commercial and Strategy Officer

Lisa von Moltke - Chief Medical Officer

Marella Thorell - CFO

Matthew Henn - EVP, Chief Scientific Officer

Conference Call Participants

Ted Tenthoff - Piper Sandler

John Newman - Canaccord Genuity

Tess Romero - JPMorgan

Jeff Jones - Oppenheimer

Keay Nakae - Chardan

Presentation

Operator

Thank you for standing by. My name is Alex, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q1 2024 Seres Therapeutics Earnings Conference Call [Operator Instructions].

I would now like to turn the call over to Carlo Tanzi, Investor Relations. Please go ahead....

For further details see: